Antibiotic-Resistant Helicobacter pylori Strains in Portuguese Children
- 1 May 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 24 (5), 404-409
- https://doi.org/10.1097/01.inf.0000160941.65324.6b
Abstract
Data concerning the effectiveness of Helicobacter pylori eradication regimens based in antibiotic susceptibility testing are scanty in children. To identify the prevalence of antibiotic resistance in H. pylori strains isolated from Portuguese children in 1999-2003; to evaluate eradication rate after antibiotic susceptibility testing-based treatment; and to identify factors associated with resistance and eradication outcome. Included were 109 children with a gastric biopsy culture positive for H. pylori. First treatment (amoxicillin, omeprazole and clarithromycin or metronidazole) was guided by susceptibility testing (E test), and eradication was assessed by [C]urea breath test. Strains were susceptible to amoxicillin and tetracycline; 39.4% were resistant to clarithromycin, 16.5% to metronidazole and 4.5% to ciprofloxacin. No significant association was found between resistance and sex, age, clinical status, gastritis scores, H. pylori density scores and genotype. Clarithromycin resistance was significantly associated with European origin [odds ratio (OR), 3.9], previous H. pylori empiric therapy (OR 2.8) and amoxicillin minimal inhibitory concentration, > or =0.016 (OR 6.0). Eradication rate after susceptibility-based treatment was 74.7% (59 of 79; 95% confidence interval, 65.9-82.9), and a significant association was found between eradication failure and presence of resistance to 1 or more antibiotics (P < 0.05). The prevalence of H. pylori antibiotic resistance was high in the studied population. The modest therapeutic success of clarithromycin and metronidazole susceptibility-based regimens suggests that in addition to resistance, other factors may be involved. The need of susceptibility-based treatment studies in children and of antimicrobial resistance surveillance in high prevalence areas for H. pylori are emphasized.Keywords
This publication has 41 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- European Multicentre Survey of in Vitro Antimicrobial Resistance in Helicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Helicobacter pylori in Children: Acquisition of Antimicrobial Resistance after an Initial Course of Treatment Journal of Clinical Microbiology, 2001
- Predictors of failure of Helicobacter pylori eradication with the standard ‘Maastricht triple therapy’Alimentary Pharmacology & Therapeutics, 2001
- Clarithromycin Resistance and Eradication of Helicobacter pylori in ChildrenAntimicrobial Agents and Chemotherapy, 2001
- Resistance of Helicobacter pylori to antibiotics and its impact on treatment optionsDrug Resistance Updates, 2001
- Choosing Triple Therapy for Helicobacter pylori in Children: Antimicrobial Resistance Testing of First Gastric Biopsy Culture May Predict OutcomeJournal of Pediatric Gastroenterology and Nutrition, 2001
- Helicobacter pylori Infection in Children: Recommendations for Diagnosis and TreatmentJournal of Pediatric Gastroenterology and Nutrition, 2000
- Helicobacter pylori Infection in Children: A Consensus StatementJournal of Pediatric Gastroenterology and Nutrition, 2000
- ACQUIRED RESISTANCE OF HELICOBACTER PYLORI STRAINSJournal of Pediatric Gastroenterology and Nutrition, 1999